featured
Rucaparib Monotherapy as First-Line Maintenance Treatment for Newly Diagnosed Ovarian Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45)
J. Clin. Oncol 2022 Jun 06;[EPub Ahead of Print], BJ Monk, C Parkinson, MC Lim, DM O'Malley, A Oaknin, MK Wilson, RL Coleman, D Lorusso, P Bessette, S Ghamande, A Christopoulou, D Provencher, E Prendergast, F Demirkiran, O Mikheeva, O Yeku, A Chudecka-Glaz, M Schenker, RD Littell, T Safra, HH Chou, MA Morgan, V Drochýtek, JN Barlin, T Van Gorp, F Ueland, G Lindahl, C Anderson, DC Collins, K Moore, F Marme, SN Westin, IA McNeish, D Shih, KK Lin, S Goble, S Hume, K Fujiwara, RS KristeleitFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.